Efficacy and Safety of Trimetazidine (Сarmetadin) in the Comprehensive Treatment of Patients With Ischemic Heart Disease and Chronic Heart Failure

HYPERTENSION
doi 10.22141/2224-1485.1.57.2018.125496
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Publishing House Zaslavsky

Related search

Efficacy and Safety of Goreisan for Chronic Heart Failure Patients With Chronic Kidney Disease

Kampo Medicine
2019English

Efficacy of Adjunctive Treatment With Trimetazidine for Fragmented QRS Among Patients With Ischemic Heart Failure: A Propensity Score Match Analysis

The European Research Journal
2019English

Trimetazidine Therapy Influence on Heart Rate Variability in Patients With Stable Ischemic Heart Disease

Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular MedicineCardiology
2014English

Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure ― J-Shift Study ―

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Efficacy and Safety of Tolvaptan in Heart Failure Patients With Volume Overload

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

The Possibility of Usage of Metabolic Correction Therapy in Patients With Ischemic Heart Disease and Heart Failure

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2007English

Incidence of Heart Failure Among Diabetic Patients With Ischemic Heart Disease: A Cohort Study

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2020English

A Review of the Current Management of Acute and Chronic Heart Failure in the Context of Ischemic Heart Disease

Continuing Cardiology Education
2017English

Safety and Efficacy of Adaptive Servo-Ventilation in Patients With Severe Systolic Heart Failure

Journal of Cardiology
Cardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy